Latest filing published 01 Jun 2023 for TCR2 THERAPEUTICS INC..
Filing timeline
BuySaleInsider track record
Peter Olagunju: trading record in brief
All filings by Peter Olagunju on record concern TCR2 Therapeutics Inc. We count 10 filings; the first trade dates from 1 December 2022 and the latest from 1 June 2023.
No open-market purchase appears, only 8 sales worth €13k. The rest of the record consists of 1 option exercise.
On 1 June 2023 came the latest disclosure, a transaction in TCR2 Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter Olagunju
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 24,092 sharesCommon StockSEC:0001104659-23-067064:0
- 1,561 shares@ US$1.13133.2% of flowCommon StockSEC:0000899243-22-038384:0
- 1,378 shares@ US$1.28233.5% of flowCommon StockSEC:0000899243-22-038096:0
- 1,291 shares@ US$1.36833.3% of flowCommon StockSEC:0000899243-22-037942:0
- 33,409 sharesCommon StockSEC:0001209191-22-059882:0
5 of 5 declarations
